News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Major ‘plasmaMATCH’ trial uses blood test to match women with breast cancer to range of precision treatments
A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal.
Immune system could be trained to spot drug-resistant cancers
Aggressive cancers could be treated with immunotherapies that direct the immune system to kill cancer cells with specific drug resistance-causing mutations, a major new study suggests.
Scientific achievements of 2019
We've selected a range of discoveries from 2018/19 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
New test predicts chance of living more than a year on targeted breast cancer treatment
A new test could pick out women with advanced breast cancer who are likely to benefit from an exciting new targeted therapy for more than a year.
ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy
The Institute of Cancer Research, London, welcomes the approval by NICE of the innovative targeted cancer treatment palbociclib for women with advanced breast cancer who have already received hormone therapy.
How ICR researchers are leading the way in breast cancer research
In Breast Cancer Awareness Month, Rose Wu looks at some of the recent research breakthroughs by breast cancer researchers at the ICR
New evolution-busting drug overcomes resistance in aggressive breast cancers
A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
Cancer trades in sugar for fatty acids in order to spread around the body
Scientists have uncovered a crucial change in cancer cells that allows them to spread around the body – by switching from sugar to fatty acids to fuel their growth.
ASCO 2019: New blood test predicts breast cancer’s return at start of treatment
A new blood test for women with breast cancer can predict how well patients will respond to a new drug right at the start of treatment.
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy
Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.
.png?sfvrsn=e5be7df6_2 "Cell division (green 4.3)")
Cell death triggers keep cancer at bay in healthy cells
Two molecules with the power of life and death over cells also play a key role in protecting the genome and preventing cancer, a major new study reveals.
Scientific achievements of 2018
We've selected a range of discoveries from 2017/18 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
